Suppr超能文献

揭示亚洲临床、环境和海鲜样本中分离出的细菌的抗菌药物耐药性特征及相关因素:一项系统综述和荟萃分析。

Revealing antimicrobial resistance profile and associated factors of isolated from clinical, environmental, and seafood samples across asia: A systematic review and meta-analysis.

作者信息

Tanveer Maryum, Ntakiyisumba Eurade, Won Gayeon

机构信息

College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan Campus, Gobong-ro 79, Iksan, 54596, South Korea.

出版信息

Heliyon. 2024 Nov 19;10(23):e40334. doi: 10.1016/j.heliyon.2024.e40334. eCollection 2024 Dec 15.

Abstract

The escalating antimicrobial resistance (AMR) in highly virulent poses a significant public health concern in Asia. Profiling the antibiogram of this pathogen is crucial for revealing its complex AMR patterns and guiding the selection of appropriate medications. Although previous studies have provided valuable insights regarding AMR, they are constrained by limited sample diversity, inconsistent methodologies, and insufficient regional data. Moreover, no systematic attempt has been made to synthesize AMR data across various sources and regions in Asia. A systematic review and meta-analysis are thus conducted in this study to assess the current AMR status of isolated from clinical, environmental, and seafood samples. By synthesizing data from 32 articles across 13 Asian countries, a broader antibiogram has been provided, covering 13 major antimicrobial groups against . Subgroup and regression analyses were also performed using study-level and country-specific covariates to explore the associated risk factors. The findings revealed low AMR rates for tetracyclines (4.89 %), quinolones (1.85 %), nitrofurans (0.86 %), and phenicols (0.61 %), highlighting their potential as primary treatment options. Conversely, high AMR rates were detected for lincosamides (80.32 %), polypeptides (64.42 %), and glycopeptides (56.14 %), necessitating careful consideration for their clinical use. For study-level covariates, subgroup and meta-regression analyses revealed that variations in the type of antimicrobial (  = 26.5 %,  < 0.0001), country (  = 18.33 %,  < 0.0001), and pathogen source (  = 10.46 %,  = 0.0007) significantly contributed to between-study heterogeneity in the detected AMR rates across studies. Moreover, the analyses of country-specific covariates indicated that antimicrobial consumption (AMC) in healthcare systems (  = 29.3,  = 0.06) and the country's gross domestic product (GDP) (  = 28.59,  = 0.06) affected the variations in AMR rates across countries to some extent. Consideration of study-level and country-specific covariates is thus recommended for future research to effectively mitigate the threat of AMR across Asia and reduce its pervasive impact on public health.

摘要

高毒力病原体中不断升级的抗菌药物耐药性(AMR)在亚洲构成了重大的公共卫生问题。分析这种病原体的抗菌谱对于揭示其复杂的AMR模式以及指导合适药物的选择至关重要。尽管先前的研究提供了有关AMR的宝贵见解,但它们受到样本多样性有限、方法不一致以及区域数据不足的限制。此外,尚未有人系统地尝试整合亚洲不同来源和地区的AMR数据。因此,本研究进行了一项系统评价和荟萃分析,以评估从临床、环境和海鲜样本中分离出的病原体的当前AMR状况。通过综合来自13个亚洲国家的32篇文章的数据,提供了更广泛的抗菌谱,涵盖了针对该病原体的13种主要抗菌药物类别。还使用研究水平和国家特定的协变量进行了亚组分析和回归分析,以探索相关的风险因素。研究结果显示,四环素(4.89%)、喹诺酮类(1.85%)、硝基呋喃类(0.86%)和氯霉素类(0.61%)的AMR率较低,突出了它们作为主要治疗选择的潜力。相反,检测到林可酰胺类(80.32%)、多肽类(64.42%)和糖肽类(56.14%)的AMR率较高,因此在临床使用时需要仔细考虑。对于研究水平的协变量,亚组分析和荟萃回归分析显示,抗菌药物类型(I² = 26.5%,P < 0.0001)、国家(I² = 18.33%,P < 0.0001)和病原体来源(I² = 10.46%,P = 0.0007)的差异对各研究中检测到的AMR率的研究间异质性有显著贡献。此外,对国家特定协变量的分析表明,医疗保健系统中的抗菌药物消费(AMC)(β = 29.3,P = 0.06)和国家国内生产总值(GDP)(β = 28.59,P = 0.06)在一定程度上影响了各国AMR率的差异。因此,建议未来的研究考虑研究水平和国家特定的协变量,以有效减轻亚洲各地病原体AMR的威胁,并减少其对公共卫生的普遍影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c3/11635644/f5e3dd312d8b/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验